brbiotechXXXX zoominfoXXXX/c/burning-rock-biotech/426006520 Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage